1. Jakobsen, JC, Katakam, KK, Schou, A, Hellmuth, SG, Stallknecht, SE
Leth-Moller, K et al. (2017) Selective serotonin reuptake inhibitors versus placebo in patients with major depressive disorder. A systematic review with meta-analysis and Trial Sequential Analysis. BMC Psychiatry 17, 58.
2. Hieronymus, F, Lisinski, A, Naslund, J
Eriksson, E ( 2018) Multiple possible inaccuracies cast doubt on a recent report suggesting selective serotonin reuptake inhibitors to be toxic and ineffective. Acta Neuropsychiatr. 30, 244–250.
3. Katakam, KK, Sethi, NJ, Jakobsen, JC
Gluud, C (2018) Great boast, small roast on effects of selective serotonin reuptake inhibitors: response to a critique of our systematic review. Acta Neuropsychiatr 30, 251–265.
4. Jakobsen, JC, Katakam, KK, Schou, A, Hellmuth, SG, Stallknecht, SE
Leth-Moller, K et al. (2017) Erratum to: selective serotonin reuptake inhibitors versus placebo in patients with major depressive disorder. A systematic review with meta-analysis and Trial Sequential Analysis. BMC Psychiatry 17, 162.
5. Thase, ME, Larsen, KG
Kennedy, SH (2011) Assessing the ‘true’ effect of active antidepressant therapy v. placebo in major depressive disorder: use of a mixture model. Br J Psychiatry 199, 501–507.
6. Melander, H, Salmonson, T, Abadie, E
van Zwieten-Boot, B (2008) A regulatory Apologia--a review of placebo-controlled studies in regulatory submissions of new-generation antidepressants. Eur Neuropsychopharmacol 18, 623–627.
7. Hieronymus, F, Emilsson, JF, Nilsson, S
Eriksson, E (2016) Consistent superiority of selective serotonin reuptake inhibitors over placebo in reducing depressed mood in patients with major depression. Mol Psychiatry 21, 523–530.
8. Leucht, S, Hierl, S, Kissling, W, Dold, M
Davis, JM (2012) Putting the efficacy of psychiatric and general medicine medication into perspective: review of meta-analyses. Br J Psychiatry 200, 97–106.
9. Geddes, JR, Carney, SM, Davies, C, Furukawa, TA, Kupfer, DJ
Frank, E et al. (2003) Relapse prevention with antidepressant drug treatment in depressive disorders: a systematic review. Lancet 361, 653–661.
10. Cipriani, A, Furukawa, TA, Salanti, G, Chaimani, A, Atkinson, LZ
Ogawa, Y et al. (2018) Comparative efficacy and acceptability of 21 antidepressant drugs for the acute treatment of adults with major depressive disorder: a systematic review and network meta-analysis. Lancet 391, 1357–1366.